BACKGROUND: The acute effect, of ethanol (EOH) include lowered blood pressure through peripheral vasodilation and decreased circulating blood volume. This study was aimed at examing the effects of EOH on the hemodynamic response to up and down head tilts. METHODS: Ten 21 to 23 year old male adults served as subjects. Each subject participated in both control and EOH experiments. In the EOH experiment, 3 mls of 25% EOH per liter of total body water was administered orally, 35 min were allowed for the blood EOH level to reach maximum before the tilt protocol was initiated. The tilt protocol consisted of 5 stages, each stage was 3-min in duration : supine (0 degrees)-head down tilt (HDT, 15 degrees)-supine (0 degrees)-head up tilt (HUT, 25 degrees)-supine (0 degrees). Hemodynamic parameters were measured with an impedance cardiograph (NCCOM3-R7, BoMed) with two electrodes placed around the neck and two around the thorax. Blood pressure (BP) was measured with an automatic sphygmomanometer (DATEX). Data was collected during every second half-minute throughout the duration of the protocol. RESULTS: In the control, HDT produced an increase in the end-diastolic index (EDI), the stroke index (SI), the cardiac index (CI), and the peak flow index (PFI) ; there were no significant changes in heart rate (HR), the systemic vascular resistance index (SVRI), and BP. In contrast, HUT resulted in a decrease in EDI, SI, EF, CI, and PFI and an increase in HR, SVRI, and BP ; the latter changes sugges a sympathetic overactivation. In the EOH experiment, the basal EDI, SI, and systolic BP were lower and HR was higher than in control. HDT and HUT caused similar changes as in control experiments. CONCLUSIONS: There results indicate that EOH cause volume depletion to result in reduced central blood volume and compensatory tachycardia. These EOH-induced changes were not altered by 15 degreeshead-down and 25 degreeshead-up tilts.
Adult ; Blood Pressure ; Blood Volume ; Body Water ; Cardiography, Impedance ; Eating* ; Electric Impedance ; Electrodes ; Ethanol* ; Gravitation ; Head ; Heart Rate ; Hemodynamics* ; Humans ; Male ; Neck ; Sphygmomanometers ; Stroke ; Tachycardia ; Thorax ; Vascular Resistance ; Vasodilation ; Young Adult

Timely recognition of diabetes risk by primary care physicians facilitates appropriate interventions, reducing the risk of complications and improving quality of life in diabetics. Therefore, primary care physicians diagnosing diabetes must be aware of the advantages and disadvantages of various tests. Diabetes can be diagnosed by plasma blood glucose, glycated hemoglobin, or oral glucose tolerance testing. Since the fasting plasma blood glucose test has low sensitivity for diagnosing diabetes, it should be combined with glycated hemoglobin or oral glucose tolerance testing. In particular, in the case of glycated hemoglobin of 6.1% or more, fasting plasma glucose of 110~125 mg/dL, or with a risk factor for diabetes, the oral glucose tolerance test should be performed. The two important criteria that distinguish type 1 from type 2 diabetes are islet autoantibody status and C-peptide. If patients are autoantibody-positive or have a C-peptide level less than 0.6 ng/mL, a diagnosis of type 1 diabetes is suggested. Monogenic diabetes is likely among patients under the age of 35 (mainly under the age of 25) with one or more of the following features: A1C < 7.5% at diagnosis, one parent with diabetes, and features of a specific monogenic cause. In that case, primary care physicians should request a genetic test.

Timely recognition of diabetes risk by primary care physicians facilitates appropriate interventions, reducing the risk of complications and improving quality of life in diabetics. Therefore, primary care physicians diagnosing diabetes must be aware of the advantages and disadvantages of various tests. Diabetes can be diagnosed by plasma blood glucose, glycated hemoglobin, or oral glucose tolerance testing. Since the fasting plasma blood glucose test has low sensitivity for diagnosing diabetes, it should be combined with glycated hemoglobin or oral glucose tolerance testing. In particular, in the case of glycated hemoglobin of 6.1% or more, fasting plasma glucose of 110~125 mg/dL, or with a risk factor for diabetes, the oral glucose tolerance test should be performed. The two important criteria that distinguish type 1 from type 2 diabetes are islet autoantibody status and C-peptide. If patients are autoantibody-positive or have a C-peptide level less than 0.6 ng/mL, a diagnosis of type 1 diabetes is suggested. Monogenic diabetes is likely among patients under the age of 35 (mainly under the age of 25) with one or more of the following features: A1C < 7.5% at diagnosis, one parent with diabetes, and features of a specific monogenic cause. In that case, primary care physicians should request a genetic test.

Timely recognition of diabetes risk by primary care physicians facilitates appropriate interventions, reducing the risk of complications and improving quality of life in diabetics. Therefore, primary care physicians diagnosing diabetes must be aware of the advantages and disadvantages of various tests. Diabetes can be diagnosed by plasma blood glucose, glycated hemoglobin, or oral glucose tolerance testing. Since the fasting plasma blood glucose test has low sensitivity for diagnosing diabetes, it should be combined with glycated hemoglobin or oral glucose tolerance testing. In particular, in the case of glycated hemoglobin of 6.1% or more, fasting plasma glucose of 110~125 mg/dL, or with a risk factor for diabetes, the oral glucose tolerance test should be performed. The two important criteria that distinguish type 1 from type 2 diabetes are islet autoantibody status and C-peptide. If patients are autoantibody-positive or have a C-peptide level less than 0.6 ng/mL, a diagnosis of type 1 diabetes is suggested. Monogenic diabetes is likely among patients under the age of 35 (mainly under the age of 25) with one or more of the following features: A1C < 7.5% at diagnosis, one parent with diabetes, and features of a specific monogenic cause. In that case, primary care physicians should request a genetic test.

Timely recognition of diabetes risk by primary care physicians facilitates appropriate interventions, reducing the risk of complications and improving quality of life in diabetics. Therefore, primary care physicians diagnosing diabetes must be aware of the advantages and disadvantages of various tests. Diabetes can be diagnosed by plasma blood glucose, glycated hemoglobin, or oral glucose tolerance testing. Since the fasting plasma blood glucose test has low sensitivity for diagnosing diabetes, it should be combined with glycated hemoglobin or oral glucose tolerance testing. In particular, in the case of glycated hemoglobin of 6.1% or more, fasting plasma glucose of 110~125 mg/dL, or with a risk factor for diabetes, the oral glucose tolerance test should be performed. The two important criteria that distinguish type 1 from type 2 diabetes are islet autoantibody status and C-peptide. If patients are autoantibody-positive or have a C-peptide level less than 0.6 ng/mL, a diagnosis of type 1 diabetes is suggested. Monogenic diabetes is likely among patients under the age of 35 (mainly under the age of 25) with one or more of the following features: A1C < 7.5% at diagnosis, one parent with diabetes, and features of a specific monogenic cause. In that case, primary care physicians should request a genetic test.

Timely recognition of diabetes risk by primary care physicians facilitates appropriate interventions, reducing the risk of complications and improving quality of life in diabetics. Therefore, primary care physicians diagnosing diabetes must be aware of the advantages and disadvantages of various tests. Diabetes can be diagnosed by plasma blood glucose, glycated hemoglobin, or oral glucose tolerance testing. Since the fasting plasma blood glucose test has low sensitivity for diagnosing diabetes, it should be combined with glycated hemoglobin or oral glucose tolerance testing. In particular, in the case of glycated hemoglobin of 6.1% or more, fasting plasma glucose of 110~125 mg/dL, or with a risk factor for diabetes, the oral glucose tolerance test should be performed. The two important criteria that distinguish type 1 from type 2 diabetes are islet autoantibody status and C-peptide. If patients are autoantibody-positive or have a C-peptide level less than 0.6 ng/mL, a diagnosis of type 1 diabetes is suggested. Monogenic diabetes is likely among patients under the age of 35 (mainly under the age of 25) with one or more of the following features: A1C < 7.5% at diagnosis, one parent with diabetes, and features of a specific monogenic cause. In that case, primary care physicians should request a genetic test.

No Abstract Available.
Cataract*

No abstract available.
Animals ; Bacteria* ; Carcinoma, Lewis Lung* ; Lactic Acid* ; Mice* ; Sarcoma 180* ; Sarcoma*

No abstract available.
Female ; Fibronectins* ; Hypertension, Pregnancy-Induced* ; Plasma* ; Pregnancy ; Pregnancy*

Fracture of the femoral neck occurred after internal fixation of intertrochanteric fracture of the femur is very rare and have been described previously in terms of stress fracture, stress-riser fracture, Youngs modulus fracture or iatrogenic fracture in the literature. This fracture documented about 20 cases in the English literature and usually occurred in elderly patients with osteoporosis and it always occur in the subcapital region. We report a case of subcapital stress fracture of the femur occurred after internal fixation with compression hip screw of intertrochanteric femur fracture.
Aged ; Elastic Modulus ; Femur Neck ; Femur* ; Fractures, Stress* ; Hip ; Humans ; Osteoporosis